Similar Incidence of Typhlitis in Patients Receiving Various Doses of Daunorubicin or Idarubicin as Induction for Acute Myeloid Leukemia
Document Type
Article
Publication Date
2018
Recommended Citation
Seddon, A. N., Chaim, J., Akin, O., Drill, E., Michael, A. G., Adel, N., & Tallman, M. S. (2018). Similar Incidence of Typhlitis in Patients Receiving Various Doses of Daunorubicin or Idarubicin as Induction for Acute Myeloid Leukemia. Leukemia Research, 68, 48-50. https://doi.org/10.1016/j.leukres.2018.03.004
Publisher's Statement
The original material can be found here: https://doi.org/10.1016/j.leukres.2018.03.004
